Revascularization Device, International Medical Device Company

Delivering High-Quality, Affordable Medical Solutions to Patients Worldwide

Zylox-Tonbridge Medical Technology Co., Ltd. is a company dedicated to the innovative research and development, manufacturing, and sales of medical devices in the field of vascular intervention.

Zylox-Tonbridge adheres to the brand philosophy of "Innovation for Quality Life", striving to provide patients with high-quality and affordable medical devices and solutions, ensuring that everyone can enjoy a high quality of life enabled by advanced medical technology.

Explore More

Product Pipeline

Commercialized and In-Development Products

Clinically Used Products

Number of Products in Clinical Use

1,100,000

NMPA

Approved Products

Products Commercialized Internationally

Across global markets

29₊

Global Presence

Across Countries and Regions

80₊

News from Zylox-Tonbridge

Aug. 20 2026

Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%

Revenue rose 31.1% to RMB 632 million, while net profit increased 47.8% to RMB 179 millionHANGZHOU, China, August 20, 2026 — Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonb...

Aug. 13 2026

From Mom and Dad's Workplace to a Wider World: A Summer Camp for Zylox-Tonbridge Families

Zylox-Tonbridge’s first residential summer camp for employees’ children combined sports, educational visits, and group living in a six-day program to foster independence, curiosity, and teamwork. Th...

Apr. 24 2026

Zylox-Tonbridge Hosts Investor Open Day, Showcasing Innovation Pipeline and Global Growth Strategy

Zhuhai, China — January 11, 2026 — Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190), a leading innovator in neurovascular and peripheral vascular interventional solutions, hosted its Invest...

Mar. 08 2024

Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions

HANGZHOU, CHINA, MAR 7th, 2024 – Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market in China, today announc...

Mar. 30 2023

Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 Million and Gross Profit Reaches RMB 253 Million

On March 29, 2023, Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, hereinafter referred to as the "Company") released its annual financial results for 2022. During the reporting peri...